Gerdien A. Tramper‐Stranders

2.4k total citations
51 papers, 1.0k citations indexed

About

Gerdien A. Tramper‐Stranders is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gerdien A. Tramper‐Stranders has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 20 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gerdien A. Tramper‐Stranders's work include Cystic Fibrosis Research Advances (14 papers), Pneumonia and Respiratory Infections (12 papers) and Respiratory viral infections research (9 papers). Gerdien A. Tramper‐Stranders is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Pneumonia and Respiratory Infections (12 papers) and Respiratory viral infections research (9 papers). Gerdien A. Tramper‐Stranders collaborates with scholars based in Netherlands, Belgium and United Kingdom. Gerdien A. Tramper‐Stranders's co-authors include Cornelis K. van der Ent, Tom F.W. Wolfs, Jan L. L. Kimpen, Rudi W. Hendriks, Gert‐Jan Braunstahl, Geertje M. de Boer, André Fleer, Jeroen G. Noordzij, Hettie M. Janssens and Mireille van Westreenen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gerdien A. Tramper‐Stranders

49 papers receiving 985 citations

Peers

Gerdien A. Tramper‐Stranders
Graham Mills New Zealand
Gary Connett United Kingdom
Hannah Thornton United Kingdom
John May United Kingdom
Myreen Tomas United States
Noel Karalus New Zealand
Gerdien A. Tramper‐Stranders
Citations per year, relative to Gerdien A. Tramper‐Stranders Gerdien A. Tramper‐Stranders (= 1×) peers Marco Mantero

Countries citing papers authored by Gerdien A. Tramper‐Stranders

Since Specialization
Citations

This map shows the geographic impact of Gerdien A. Tramper‐Stranders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerdien A. Tramper‐Stranders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerdien A. Tramper‐Stranders more than expected).

Fields of papers citing papers by Gerdien A. Tramper‐Stranders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerdien A. Tramper‐Stranders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerdien A. Tramper‐Stranders. The network helps show where Gerdien A. Tramper‐Stranders may publish in the future.

Co-authorship network of co-authors of Gerdien A. Tramper‐Stranders

This figure shows the co-authorship network connecting the top 25 collaborators of Gerdien A. Tramper‐Stranders. A scholar is included among the top collaborators of Gerdien A. Tramper‐Stranders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerdien A. Tramper‐Stranders. Gerdien A. Tramper‐Stranders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tramper‐Stranders, Gerdien A., et al.. (2025). Moderate-to-late prematurity: understanding respiratory consequences and modifiable risk factors. European Respiratory Review. 34(176). 240267–240267.
2.
Keij, Fleur M., Gerdien A. Tramper‐Stranders, René F. Kornelisse, et al.. (2024). A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta‐Lactamase Inhibition. Clinical Pharmacology & Therapeutics. 117(1). 193–202. 2 indexed citations
3.
Feleszko, Wojciech, Alessandra Arcolacı, Marina Atanasković‐Marković, et al.. (2024). A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report. Clinical and Translational Allergy. 14(3). e12345–e12345. 2 indexed citations
4.
Veen, J.C.C.M. in ’t, Lisette Krabbendam, Geertje M. de Boer, et al.. (2024). Aberrant characteristics of peripheral blood innate lymphoid cells in COPD, independent of smoking history. ERJ Open Research. 10(1). 652–2023. 2 indexed citations
6.
Veen, Mirjam van, Marlies A. van Houten, Jantien W. Wieringa, et al.. (2023). Adverse effect of lockdowns during the COVID-19 pandemic: increased incidence of pediatric crisis admissions due to eating disorders and adolescent intoxications. European Journal of Pediatrics. 182(3). 1137–1142. 11 indexed citations
7.
Keij, Fleur M., Gerdien A. Tramper‐Stranders, Birgit C. P. Koch, et al.. (2022). Pharmacokinetics of Clavulanic Acid in the Pediatric Population: A Systematic Literature Review. Clinical Pharmacokinetics. 61(5). 637–653. 9 indexed citations
8.
Tramper‐Stranders, Gerdien A., Alessandra Arcolacı, Marina Atanasković‐Marković, et al.. (2021). Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases. Allergy. 76(11). 3276–3291. 14 indexed citations
9.
Boer, Geertje M. de, Gerdien A. Tramper‐Stranders, Nadine Pouw, et al.. (2021). Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index. Respiratory Medicine. 188. 106603–106603. 17 indexed citations
10.
Kruizinga, Matthijs D., Mirjam van Veen, Marlies van Houten, et al.. (2021). The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature. European Journal of Pediatrics. 180(7). 2271–2279. 131 indexed citations
12.
Maat, Josephine van de, Gertjan J. A. Driessen, Frank J. Smit, et al.. (2021). The influence of chest X-ray results on antibiotic prescription for childhood pneumonia in the emergency department. European Journal of Pediatrics. 180(9). 2765–2772. 8 indexed citations
13.
14.
Prevaes, Sabine M. P. J., Gerdien A. Tramper‐Stranders, Raïza Hasrat, et al.. (2020). Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment. Journal of Cystic Fibrosis. 19(4). 553–561. 45 indexed citations
15.
Tramper‐Stranders, Gerdien A.. (2017). Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies. Paediatric Respiratory Reviews. 26. 41–48. 45 indexed citations
16.
Prevaes, Sabine M. P. J., Wouter A. A. de Steenhuijsen Piters, Karin M. de Winter‐de Groot, et al.. (2017). Concordance between upper and lower airway microbiota in infants with cystic fibrosis. European Respiratory Journal. 49(3). 1602235–1602235. 55 indexed citations
17.
Prevaes, Sabine M. P. J., Karin M. de Winter‐de Groot, Hettie M. Janssens, et al.. (2015). Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 193(5). 504–515. 101 indexed citations
18.
Tramper‐Stranders, Gerdien A., Tom F.W. Wolfs, W. M. C. van Aalderen, et al.. (2010). Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Thorax. 65(10). 915–920. 30 indexed citations
19.
Slieker, Martijn G., Josephus P. J. van Gestel, Harry Heijerman, et al.. (2006). Outcome of assisted ventilation for acute respiratory failure in cystic fibrosis. Intensive Care Medicine. 32(5). 754–758. 25 indexed citations
20.
Tramper‐Stranders, Gerdien A., Tom F.W. Wolfs, André Fleer, Jan L. L. Kimpen, & Cornelis K. van der Ent. (2006). Maintenance Azithromycin Treatment in Pediatric Patients With Cystic Fibrosis. The Pediatric Infectious Disease Journal. 26(1). 8–12. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026